TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Ferring Pharmaceuticals A/S
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
1,457,509
|
1,261,432
|
1,005,468 |
Earnings before taxes |
86,235
|
63,945
|
52,059 |
Total assets |
586,405
|
485,671
|
472,880 |
Current assets |
328,564
|
215,513
|
226,702 |
Current liabilities |
315,813
|
255,819
|
269,084 |
Equity capital |
189,325
|
121,995
|
69,618 |
- share capital |
500
![]() |
500
![]() |
500 |
Employees (average) |
350
![]() |
350
![]() |
350 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
32.3%
|
25.1%
|
14.7% |
Turnover per employee |
4,164
|
3,604
|
2,873 |
Profit as a percentage of turnover |
5.9%
|
5.1%
|
5.2% |
Return on assets (ROA) | |||
Current ratio |
104.0%
|
84.2%
![]() |
84.2% |
Return on equity (ROE) |
45.5%
|
52.4%
|
74.8% |
Change turnover |
196,077
|
255,964
|
-46,000 |
Change turnover % |
16%
|
25%
|
-4% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.